TAGP yields 2000.00% · JNJ yields 2.13%● Live data
📍 TAGP pulled ahead of the other in Year 1
Combined, TAGP + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TAGP + JNJ for your $10,000?
Tristar Acquisition Group operates as an engineering, procurement, and construction contractor. The company, through its subsidiaries, engages in the design, fabrication, and installation of specialized equipment, known as packages or skids, and production plants for the oil and gas industry and engineering companies. It also designs, manufactures, and markets oil and gas production equipments and systems primarily for the oil and gas production separation process. The company's products and services are used for the separation of unprocessed hydrocarbon fluids into sellable oil and gas, as well as used in the production of crude oil and natural gas to separate oil, gas, and water within a production stream and to remove contaminants. Its products and services are also deployed in downstream operations, such as in refining units, pipeline, LNG liquefaction, and electric generation; and in upstream operations, including wellhead completion, collection center, the first treatment unit, and the process treatment unit. Tristar Acquisition Group installs its products on onshore facilities, as well as in offshore floating production, storage, and offloading vessels. It offers its products primarily in Belarus, Italy, Egypt and the Middle East, the United States, and internationally. Tristar Acquisition Group is headquartered in Rome, Italy.
Full TAGP Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.